加入我们

  苏州艾博生物科技有限公司致力于基于核酸(siRNA, mRNA, DNA)的新药研发,目标疾病包括癌症和传染病。公司创始人在核酸药物研发领域有多年的经验,其设计的多个药品在美国已经入临床试验阶段。公司目前在苏州建立了科研基地,依托于为核酸药物量身打造的转化平台和世界一流的科研及管理团队,我们将在未来的3~5年内有多个项目进入临床及临床报批阶段。


Suzhou Abogen Biosciences is a discovery stage biotechnology company focused on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases. We are dedicated to building the most transformative nucleic acid-based therapeutics platform, the infrastructure to facilitate and accelerate drug discovery and development,a rapidly expanding and promising pipeline, a top-notch team with seasoned scientists and entrepreneurs.